T2 Biosystms Stock Total Debt
TTOODelisted Stock | USD 0.18 0.05 21.74% |
T2 Biosystms fundamentals help investors to digest information that contributes to T2 Biosystms' financial success or failures. It also enables traders to predict the movement of TTOO Pink Sheet. The fundamental analysis module provides a way to measure T2 Biosystms' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to T2 Biosystms pink sheet.
TTOO |
T2 Biosystms Company Total Debt Analysis
T2 Biosystms' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current T2 Biosystms Total Debt | 49.5 M |
Most of T2 Biosystms' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, T2 Biosystms is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, T2 Biosystms has a Total Debt of 49.5 M. This is 98.2% lower than that of the Biotechnology sector and 94.67% lower than that of the Health Care industry. The total debt for all United States stocks is 99.07% higher than that of the company.
TTOO Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses T2 Biosystms' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of T2 Biosystms could also be used in its relative valuation, which is a method of valuing T2 Biosystms by comparing valuation metrics of similar companies.T2 Biosystms is currently under evaluation in total debt category among its peers.
TTOO Fundamentals
Return On Equity | -6.22 | ||||
Return On Asset | -0.9 | ||||
Operating Margin | (4.91) % | ||||
Current Valuation | 21.91 M | ||||
Shares Outstanding | 21.04 M | ||||
Shares Owned By Insiders | 10.17 % | ||||
Shares Owned By Institutions | 73.51 % | ||||
Number Of Shares Shorted | 826.91 K | ||||
Price To Earning | (2.04) X | ||||
Price To Book | 14.50 X | ||||
Price To Sales | 0.69 X | ||||
Revenue | 7.19 M | ||||
Gross Profit | (24.77 M) | ||||
EBITDA | (43.88 M) | ||||
Net Income | (50.08 M) | ||||
Cash And Equivalents | 13.21 M | ||||
Cash Per Share | 1.87 X | ||||
Total Debt | 49.5 M | ||||
Debt To Equity | 6.64 % | ||||
Current Ratio | 1.87 X | ||||
Book Value Per Share | (6.91) X | ||||
Cash Flow From Operations | (48.14 M) | ||||
Short Ratio | 1.26 X | ||||
Earnings Per Share | (0.03) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 113 | ||||
Beta | 0.38 | ||||
Market Capitalization | 10.48 M | ||||
Total Asset | 34.8 M | ||||
Retained Earnings | (584.3 M) | ||||
Working Capital | (30.96 M) | ||||
Current Asset | 77.78 M | ||||
Current Liabilities | 18.54 M | ||||
Net Asset | 34.8 M |
About T2 Biosystms Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze T2 Biosystms's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of T2 Biosystms using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of T2 Biosystms based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in TTOO Pink Sheet
If you are still planning to invest in T2 Biosystms check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the T2 Biosystms' history and understand the potential risks before investing.
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
CEOs Directory Screen CEOs from public companies around the world | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |